Page 25 - Vaccine

Biden administration to start offering vaccine booster shots on Sept 20

The US will begin issuing more booster shots as soon as Sept. 20 to people who received their second shot at least eight months earlier

Serum Institute picks up 50% in glass vial maker Schott's Indian JV

Deal value not disclosed; former co-promoters Kaisha exits JV

Explained: What will it take to stop delta variant of coronavirus

Delta is both more infectious and more capable of evading immunity generated by either vaccination or a previous natural infection

Moderna, BioNTech lose nearly $60 billion in value in two-day drop

The declines deepened Wednesday with Moderna closing 16% lower and BioNTech dropping 14% as trading volume picked up

Decoded: Understanding the debate over coronavirus booster shots

US Centers for Disease Control and Prevention recommends that ad­ults receive boosters of the tetanus vaccine every dec­a­de

Covid-19 pandemic: Novavax shot may get nod in India even before US

SII and Novavax have now completed submission of all modules required by regulatory agencies in India, Indonesia and the Philippines for the initiation of review of the vaccine

Covid-19 pandemic: Can Moderna buy its way into the $200 billion club?

The company disclosed during its earnings presentation Aug. 5 that it expects the shot to generate $20 billion in sales this year

Govt okays Bharat Biotech's Ankleshwar plant to produce Covaxin: Minister

Union minister Mansukh Mandaviya on Tuesday said the government has given approval to Bharat Biotech's Ankleshwar-based manufacturing plant to produce COVID-19 vaccine Covaxin. "Govt of India approves vaccine manufacturing facility for production of @BharatBiotech's #Covaxin in Ankleshwar, Gujarat," Mandaviya tweeted. The approval would help increase availability of COVID-19 vaccines in the country, he added. "Following PM @NarendraModi ji's vision of #SabkoVaccineMuftVaccine, this will increase vaccine availability & accelerate the world's largest vaccine drive," the minister who heads both Chemicals and Fertilisers and Health ministries noted. In May this year, Bharat Biotech had announced that it plans to produce an additional 200 million doses of Covaxin at its subsidiary's Ankleshwar-based facility. The Hyderabad-based firm had noted that it would utilise the manufacturing plant of its wholly-owned unit - Chiron Behring, to add another 200 million doses of Covaxin.

DRL seeks a booster from Sputnik V but hurdles in scaling up remain

Even as the company investigates complaints of malpractice in the Ukraine, hurdles in scaling up the Russian vaccine remain the bigger challenge in the near term

J&J seeks approval for single-dose Covid-19 vaccine in India

It is not clear whether J&J is seeking indemnity against adverse events following vaccination like its US peers

China pledges 2 billion Covid-19 vaccines globally through year's end

Xi Jinping pledged 2 billion doses of Chinese vaccines would be supplied to the world through this year, an increase that would add to country's efforts as the largest global exporter of vaccines

Novavax seeks OK for emergency use of Covid vaccine in India, Indonesia

Vaccine maker Novavax announced Thursday it has asked regulators in India, Indonesia and the Philippines to allow emergency use of its Covid-19 vaccine

Moderna Covid-19 vaccine tallies more than $4 billion in Q2 sales

Moderna's Covid-19 vaccine brought in more than $4 billion in second-quarter sales, helping to push the vaccine developer into a profit

Are coronavirus vaccines working? What the real world tells us

Delta, the strain first reported in India in October, is the most worrisome detected so far

Serum Institute may start Covid-19 vaccine trials on kids in August

SII will conduct trials on those aged between two to 17 years

Sanofi to buy partner Translate Bio for $3.2 billion in mRNA push

Sanofi has lagged behind upstarts BioNTech SE and Moderna Inc. in the pandemic as they raced ahead with mRNA shots that have now been injected into arms more than a billion times

Gennova to use mRNA tech to develop vaccines for Zika, tuberculosis

mRNA vaccines typically have stringent temperature requirements to remain stable

Astra's Covid-19 vaccine sales triple in Q2, top $1 billion in H1

Firm exploring whether vaccine biz is sustainable for next 5-10 years: Official

Improving vaccine distribution

Private sector channel needs to be reworked

Over 10,000 Covid vaccines administered in Delhi on Sunday: Cowin portal

The city has administered over 96 lakh doses, including 23,84,076 second doses